SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1317)7/26/2005 11:17:04 AM
From: Jibacoa  Respond to of 3722
 
In an article by John Dobosz in Forbes, he points out that the "gurus" are buying Biotech & Software companies.<g>

Among the Biotechs he mentioned are HGSI,BIIB and IDBE

forbes.com

HGSI is finding some resistance at the 15.50 level, but if it can do that it will make a 52 wks. H <g>

bigcharts.marketwatch.com

BIIB needs to close above its July 20 H of 39.56 in order to test its more important resistance at the 39.98 to 40.02 level and then try to close its February 28 downgap.<g>

bigcharts.marketwatch.com

IDBE Is trying today to get over its Friday H of 20.63 in order to make another 52 wks. H

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1317)8/2/2005 12:45:58 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
RNAI Continues on its recent uptrend.

On Friday its Sirna-027, for AMD was discussed in PBS science program, NOVA. One of RNAI's investigators, Peter Kaiser, M.D., of the Cleveland Clinic and the first patient to receive the drug, spoke about their positive experience.

According to Dr. Kaiser, the patient's vision improved and the results are "very promising".<g>

The stock has traded as high as 5.25 and still is up more than 17% as it seems it should be able to retest its July 26 H of 5.60 some time this week.<g>

bigcharts.marketwatch.com

And from a longer term perspective, the stock remains very "interesting".<g>

bigcharts.marketwatch.com

Bernard